Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 536049, 16 pages
http://dx.doi.org/10.1155/2014/536049
Research Article

Cytokine Effects on Cell Viability and Death of Prostate Carcinoma Cells

1Department of Anatomy-Histology-Embryology, Medical School, University of Ioannina, 45110 Ioannina, Greece
2Laboratory of Hematology, University Hospital of Ioannina, 45500 Ioannina, Greece
3Department of Pathology, Medical School, University of Ioannina, 45110 Ioannina, Greece
4Department of Urology, Medical School, University of Ioannina, 45110 Ioannina, Greece
5Department of Anatomy, Medical School, University of Thessaly, 44110 Larisa, Greece

Received 15 February 2014; Revised 9 April 2014; Accepted 6 May 2014; Published 29 May 2014

Academic Editor: Gary E. Gallick

Copyright © 2014 Georgios Chondrogiannis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Bouraoui, M. Ricote, I. García-Tuñón et al., “Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer,” Cancer Detection and Prevention, vol. 32, no. 1, pp. 23–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. V. Guseva, A. F. Taghiyev, O. W. Rokhlin, and M. B. Cohen, “Death receptor-induced cell death in prostate cancer,” Journal of Cellular Biochemistry, vol. 91, no. 1, pp. 70–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Rodriguez-Berriguete, B. Fraile, P. Martinez-Onsurbe, G. Olmedilla, R. Paniagua, and M. Royuela, “MAP kinases and prostate cancer,” Journal of Signal Transduction, vol. 2012, Article ID 169170, 9 pages, 2012. View at Publisher · View at Google Scholar
  5. R. R. Zielinski, B. J. Eigl, and K. N. Chi, “Targeting the apoptosis pathway in prostate cancer,” Cancer Journal, vol. 19, no. 1, pp. 79–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Maroni, S. Koul, R. B. Meacham, and H. K. Koul, “Mitogen activated protein kinase signal transduction pathways in the prostate,” Cell Communication and Signaling, vol. 2, article 5, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Royuela, G. Rodríguez-Berriguete, B. Fraile, and R. Paniagua, “TNF-α/IL-1/NF-κB transduction pathway in human cancer prostate,” Histology and Histopathology, vol. 23, no. 10, pp. 1279–1290, 2008. View at Google Scholar · View at Scopus
  8. D. P. Chopra, R. E. Menard, J. Januszewski, and R. R. Mattingly, “TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines,” Cancer Letters, vol. 203, no. 2, pp. 145–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Y. Lee, D. Y. Yuk, H. S. Song et al., “Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-κB,” European Journal of Pharmacology, vol. 582, no. 1–3, pp. 17–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ricote, I. García-Tuñón, B. Fraile et al., “P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells,” Apoptosis, vol. 11, no. 11, pp. 1969–1975, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Y. Win and M. Acevedo-Duncan, “Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival,” Cancer Letters, vol. 270, no. 2, pp. 302–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Zhang, X. Huang, and A. F. Olumi, “Repression of NF-κB and activation of AP-1 enhance apoptosis in prostate cancer cells,” International Journal of Cancer, vol. 124, no. 8, pp. 1980–1989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Zhang, T.-G. Jin, H. Yang, W. C. Dewolf, R. Khosravi-Far, and A. F. Olumi, “Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer,” Cancer Research, vol. 64, no. 19, pp. 7086–7091, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Fang, V. Hwa, and R. G. Rosenfeld, “Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway,” Experimental Cell Research, vol. 312, no. 8, pp. 1229–1239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. H. He, J. Xu, P. S. Nelson et al., “Differential expression of the α2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells,” Prostate, vol. 70, no. 9, pp. 993–1001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Albrecht, J. Doroszewicz, S. Gillen et al., “Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation,” Prostate, vol. 58, no. 1, pp. 82–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Bouraoui, N. B. Rais, Z. Culig, and R. Oueslati, “Involvement of interleukin-1β mediated nuclear factor κB signalling pathways to down-regulate prostate-specific antigen and cell proliferation in LNCaP prostate cancer cells,” Cell Biology International, vol. 36, no. 5, pp. 449–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. D. Perkins, “NF-κB: tumor promoter or suppressor?” Trends in Cell Biology, vol. 14, no. 2, pp. 64–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Chang, J. T. Lee, P. M. Navolanic et al., “Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy,” Leukemia, vol. 17, no. 3, pp. 590–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kaur, S. Uddin, and L. C. Platanias, “The PI3′ kinase pathway in interferon signaling,” Journal of Interferon and Cytokine Research, vol. 25, no. 12, pp. 780–787, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. V. Gasparian, Y. J. Yao, D. Kowalczyk et al., “The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells,” Journal of Cell Science, vol. 115, part 1, pp. 141–151, 2002. View at Google Scholar · View at Scopus
  22. S. A. Beresford, M. A. Davies, G. E. Gallick, and N. J. Donato, “Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PC-3 prostate cancer cells,” Journal of Interferon and Cytokine Research, vol. 21, no. 5, pp. 313–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Jin, Y. Lho, L. Connelly et al., “The nuclear factor-κB pathway controls the progression of prostate cancer to androgen-independent growth,” Cancer Research, vol. 68, no. 16, pp. 6762–6769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Lin, R. M. Adam, E. Santiestevan, and M. R. Freeman, “The phosphatidylinositol 3'-kinase pathway is a dominant growth factor- activated cell survival pathway in LNCaP human prostate carcinoma cells,” Cancer Research, vol. 59, no. 12, pp. 2891–2897, 1999. View at Google Scholar · View at Scopus
  25. K. Shimada, M. Nakamura, E. Ishida, and N. Konishi, “Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer,” Histology and Histopathology, vol. 21, no. 4–6, pp. 415–422, 2006. View at Google Scholar · View at Scopus
  26. C. Sweeney, L. Li, R. Shanmugam et al., “Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate,” Clinical Cancer Research, vol. 10, no. 16, pp. 5501–5507, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Wang, R. B. Montgomery, L. J. Schmidt et al., “Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression,” Cancer Research, vol. 69, no. 24, pp. 9448–9456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Zhang, S. Altuwaijri, F. Deng et al., “NF-kappaB regulates androgen receptor expression and prostate cancer growth,” The American Journal of Pathology, vol. 175, no. 2, pp. 489–499, 2009. View at Google Scholar
  29. S. Shukla, G. T. MacLennan, D. J. Hartman, P. Fu, M. I. Resnick, and S. Gupta, “Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion,” International Journal of Cancer, vol. 121, no. 7, pp. 1424–1432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Sarker, A. H. M. Reid, T. A. Yap, and J. S. De Bono, “Targeting the PI3K/AKT pathway for the treatment of prostate cancer,” Clinical Cancer Research, vol. 15, no. 15, pp. 4799–4805, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Kulik, J. P. Carson, T. Vomastek et al., “Tumor necrosis factor α induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCap cells,” Cancer Research, vol. 61, no. 6, pp. 2713–2719, 2001. View at Google Scholar · View at Scopus
  32. S. T. Palayoor, M. Y. Youmell, S. K. Calderwood, C. N. Coleman, and B. D. Price, “Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen,” Oncogene, vol. 18, no. 51, pp. 7389–7394, 1999. View at Google Scholar · View at Scopus
  33. C.-Y. Tsai, T.-S. Lee, Y. R. Kou, and Y.-L. Wu, “Glucosamine inhibits IL-1β-mediated IL-8 production in prostate cancer cells by MAPK attenuation,” Journal of Cellular Biochemistry, vol. 108, no. 2, pp. 489–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. E. Hedlund, R. C. Duke, M. S. Schleicher, and G. J. Miller, “Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage,” Prostate, vol. 36, no. 2, pp. 92–101, 1998. View at Google Scholar
  35. M. Kastamoulas, G. Chondrogiannis, P. Kanavaros et al., “Cytokine effects on cell survival and death of A549 lung carcinoma cells,” Cytokine, vol. 61, no. 3, pp. 816–825, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Darzynkiewicz, E. Bedner, and P. Smolewski, “Flow cytometry in analysis of cell cycle and apoptosis,” Seminars in Hematology, vol. 38, no. 2, pp. 179–193, 2001. View at Google Scholar · View at Scopus
  37. V. Galani, S. Constantopoulos, C. Manda-Stachouli et al., “Additional proteins in BAL fluid of metsovites environmentally exposed asbestos: more evidence of “protection” against neoplasia?” Chest, vol. 121, no. 1, pp. 273–278, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. L. C. Platanias, “Map kinase signaling pathways and hematologic malignancies,” Blood, vol. 101, no. 12, pp. 4667–4679, 2003. View at Google Scholar · View at Scopus
  39. F. Belardelli and M. Ferrantini, “Cytokines as a link between innate and adaptive antitumor immunity,” Trends in Immunology, vol. 23, no. 4, pp. 201–208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Galani, E. Tatsaki, M. Bai et al., “The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specific review,” Pathology Research and Practice, vol. 206, no. 3, pp. 145–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Parmar and L. C. Platanias, “Interferons: mechanisms of action and clinical applications,” Current Opinion in Oncology, vol. 15, no. 6, pp. 431–439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. C. A. Dinarello, “Interleukin-1 in the pathogenesis and treatment of inflammatory diseases,” Blood, vol. 117, no. 14, pp. 3720–3732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Giampietri, S. Petrungaro, F. Padula et al., “Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis,” Apoptosis, vol. 17, no. 11, pp. 1210–1222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. F. H. Igney and P. H. Krammer, “Death and anti-death: tumour resistance to apoptosis,” Nature Reviews Cancer, vol. 2, no. 4, pp. 277–288, 2002. View at Google Scholar · View at Scopus
  45. D. J. Panka, T. Mano, T. Suhara, K. Walsh, and J. W. Mier, “Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells,” The Journal of Biological Chemistry, vol. 276, no. 10, pp. 6893–6896, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. A. N. Cornforth, J. S. Davis, E. Khanifar, K. L. Nastiuk, and J. J. Krolewski, “FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells,” Oncogene, vol. 27, no. 32, pp. 4422–4433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Jin, X. Liu, Z. Zhou et al., “Activation of nuclear factor-κB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells,” Cancer Research, vol. 65, no. 14, pp. 6354–6363, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. E. V. Vykhovanets, S. Shukla, G. T. MacLennan et al., “Molecular imaging of NF-kappaB in prostate tissue after systemic administration of IL-1β,” Prostate, vol. 68, no. 1, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. E. V. Vykhovanets, S. Shukla, G. T. MacLennan, O. V. Vykhovanets, D. R. Bodner, and S. Gupta, “Il-1β-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation,” Prostate, vol. 69, no. 6, pp. 633–643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Kimura and E. P. Gelmann, “Propapoptotic effects of NF-κB in LNCaP prostate cancer cells lead to serine protease activation,” Cell Death and Differentiation, vol. 9, no. 9, pp. 972–980, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. K. Radhakrishnan and S. Kamalakaran, “Pro-apoptotic role of NF-κB: implications for cancer therapy,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1766, no. 1, pp. 53–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Ortis, P. Pirot, N. Naamane et al., “Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic beta cells,” Diabetologia, vol. 51, no. 7, pp. 1213–1225, 2008. View at Publisher · View at Google Scholar · View at Scopus